Coinspeaker MRNA Stock Down 3%, Moderna Prices New Shares at $76, Wants to Raise $1.34 BillionOn Monday, Moderna (MRNA) stock price jumped 20% after the company reported a positive date for its early-stage human trial for the COVID-19 vaccine - mRNA 1273. Now Moderna shares are around 3% down.MRNA Stock Down 3%, Moderna Prices New Shares at $76, Wants to Raise $1.34 Billion